Fig 1.
Flow chart of participants recruitment.
Fig 2.
The relationship between age and the different biochemical phenotypes of DILI.
Fig 3.
Serum alanine aminotransferase (ALT) and the different biochemical phenotypes of DILI.
Table 1.
Demographic characteristics of the study population (n = 72).
Table 2.
The Distribution of DILI implicated medications.
Table 3.
Final updated RUCAM causality assessment scale.
Fig 4.
Pairwise agreement and disagreement between rating pairs.
Table 4.
Proportion of Cohen’s kappa pairwise agreement/disagreement between rating pairs utilizing the updated RUCAM scale.